Texas A&M Baseball

D1Baseball's Kendall Rogers examines A&M's roster ahead of MLB Draft

The 2025 MLB Draft begins on Sunday night in Atlanta as Michael Earley & Co. are currently constructing Texas A&M's 2026 roster. On Wednesday morning, D1Baseball's Kendall Rogers joined TexAgs Live to discuss where the Aggies could hear their names called next week.
By Ryan Brauninger
July 9, 2025
5.2k Views
Discuss
Story Poster
Photo by Jamie Maury

The 2025 MLB Draft begins on Sunday night in Atlanta as Michael Earley & Co. are currently constructing Texas A&M's 2026 roster. On Wednesday morning, D1Baseball's Kendall Rogers joined TexAgs Live to discuss where the Aggies could hear their names called next week.


Key notes from Kendall Rogers interview

  • Entering the MLB Draft, the most interesting Aggie is Jace LaViolette, who I think I saw the Astros possibly getting him in the 20s in a recent mock draft.
To view this content, you must be a TexAgs Premium subscriber.
Try Premium for $1
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial
Discuss
Tags
Cliff Pennington Michael Earley Jason Kelly TexAgs Live TexAgs Live Feature Kendall Rogers MLB Draft Paul Mainieri Transfer Portal Jay Johnson House v. NCAA MJ Bollinger
Show All
Jake Duer Ethan Darden Chris Hacopian 2025 MLB Draft Maddox Latta Carson Bailey Ryan Prager Jace LaViolette Justin Lamkin Shane Sdao Gavin Grahovac Caden Sorrell Weston Moss Baseball Baseball Recruiting Texas A&M LSU Cal State Fullerton South Carolina Tennessee Mississippi State 2025 2026
More Baseball
See All →
B-Team: We Learned Wednesday, a soap opera in Gainesville & more
By Ryan Brauninger
FTM, Ep. 80: Cody Campbell vs. the SCORE Act, early coach firings & more
By FollowTheMoney
Catcher Bear Harrison explains A&M's increased focus on accountability
By Ryan Brauninger
D1 Baseball's most anticipated SEC series
By Ryan Brauninger
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.